Presentation is loading. Please wait.

Presentation is loading. Please wait.

A phase II single-institution study of neoadjuvant stage IIIA/B chemotherapy and radiochemotherapy in non-small cell lung cancer  Andreas Granetzny, MD,

Similar presentations


Presentation on theme: "A phase II single-institution study of neoadjuvant stage IIIA/B chemotherapy and radiochemotherapy in non-small cell lung cancer  Andreas Granetzny, MD,"— Presentation transcript:

1 A phase II single-institution study of neoadjuvant stage IIIA/B chemotherapy and radiochemotherapy in non-small cell lung cancer  Andreas Granetzny, MD, Eberhard Striehn, MD, Ulrich Bosse, MD, Wolfgang Wagner, MD, Olaf Koch, MD, Ulf Vogt, PhD, Peter Froeschle, MD, Folker Klinke, MD  The Annals of Thoracic Surgery  Volume 75, Issue 4, Pages (April 2003) DOI: /S (02)

2 Fig 1 Postoperative tumor stage (n = 26).
The Annals of Thoracic Surgery  , DOI: ( /S (02) )

3 Fig 2 Cumulative survival in clinical stage IIIA (solid line) and stage IIIB (dotted line). The difference between the two curves is not significant. The Annals of Thoracic Surgery  , DOI: ( /S (02) )

4 Fig 3 Long-term survival and remission rates in mediastinal lymph nodes. The difference between the groups with and without malignant cells in the mediastinal lymph nodes was significant (log rank p < ). Solid line = no malignant cells in mediastinal lymph node (n = 10); evenly dotted line = malignant cells in mediastinal lymph node (n = 16); and unevenly dotted line = no operation (n = 7). The Annals of Thoracic Surgery  , DOI: ( /S (02) )


Download ppt "A phase II single-institution study of neoadjuvant stage IIIA/B chemotherapy and radiochemotherapy in non-small cell lung cancer  Andreas Granetzny, MD,"

Similar presentations


Ads by Google